- Home
- MXCT vs ZVRA Comparison
MXCT vs ZVRA Comparison
Compare MXCT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- ZVRA
- Stock Information
- Founded
- MXCT 1999
- ZVRA 2006
- Country
- MXCT United States
- ZVRA United States
- Employees
- MXCT N/A
- ZVRA N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- MXCT Health Care
- ZVRA Health Care
- Exchange
- MXCT Nasdaq
- ZVRA Nasdaq
- Market Cap
- MXCT 398.3M
- ZVRA 443.6M
- IPO Year
- MXCT 2021
- ZVRA 2015
- Fundamental
- Price
- MXCT $3.46
- ZVRA $8.94
- Analyst Decision
- MXCT Strong Buy
- ZVRA Strong Buy
- Analyst Count
- MXCT 3
- ZVRA 7
- Target Price
- MXCT $8.67
- ZVRA $21.00
- AVG Volume (30 Days)
- MXCT 353.2K
- ZVRA 513.4K
- Earning Date
- MXCT 11-06-2024
- ZVRA 11-12-2024
- Dividend Yield
- MXCT N/A
- ZVRA N/A
- EPS Growth
- MXCT N/A
- ZVRA N/A
- EPS
- MXCT N/A
- ZVRA N/A
- Revenue
- MXCT $45,599,000.00
- ZVRA $23,689,000.00
- Revenue This Year
- MXCT N/A
- ZVRA N/A
- Revenue Next Year
- MXCT $23.47
- ZVRA $318.48
- P/E Ratio
- MXCT N/A
- ZVRA N/A
- Revenue Growth
- MXCT 19.85
- ZVRA 43.21
- 52 Week Low
- MXCT $3.15
- ZVRA $3.89
- 52 Week High
- MXCT $5.55
- ZVRA $9.02
- Technical
- Relative Strength Index (RSI)
- MXCT 38.39
- ZVRA 60.34
- Support Level
- MXCT $3.50
- ZVRA $7.67
- Resistance Level
- MXCT $4.15
- ZVRA $8.91
- Average True Range (ATR)
- MXCT 0.21
- ZVRA 0.36
- MACD
- MXCT 0.01
- ZVRA 0.03
- Stochastic Oscillator
- MXCT 14.81
- ZVRA 83.87
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.